BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,096 filers reported holding BAXTER INTL INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $41,742 | -33.1% | 1,106 | -19.3% | 0.01% | -33.3% |
| Q2 2023 | $62,418 | +63.7% | 1,370 | +45.7% | 0.02% | +50.0% |
| Q1 2023 | $38,128 | +124.0% | 940 | +181.4% | 0.01% | +100.0% |
| Q4 2022 | $17,024 | -43.3% | 334 | -38.7% | 0.01% | -50.0% |
| Q3 2022 | $30,000 | -55.2% | 545 | -48.1% | 0.01% | -50.0% |
| Q2 2022 | $67,000 | -23.0% | 1,051 | -6.2% | 0.02% | -13.0% |
| Q1 2022 | $87,000 | -14.7% | 1,121 | -5.7% | 0.02% | -8.0% |
| Q4 2021 | $102,000 | +7.4% | 1,189 | +0.8% | 0.02% | -10.7% |
| Q3 2021 | $95,000 | +3.3% | 1,179 | +4.0% | 0.03% | +3.7% |
| Q2 2021 | $92,000 | +7.0% | 1,134 | +10.4% | 0.03% | +3.8% |
| Q1 2021 | $86,000 | +2.4% | 1,027 | -1.7% | 0.03% | 0.0% |
| Q4 2020 | $84,000 | -24.3% | 1,045 | -24.1% | 0.03% | -33.3% |
| Q3 2020 | $111,000 | -11.2% | 1,377 | -4.8% | 0.04% | -4.9% |
| Q2 2020 | $125,000 | +10.6% | 1,447 | +4.0% | 0.04% | -4.7% |
| Q1 2020 | $113,000 | +3.7% | 1,392 | +6.8% | 0.04% | +34.4% |
| Q4 2019 | $109,000 | -0.9% | 1,303 | +3.3% | 0.03% | -11.1% |
| Q3 2019 | $110,000 | +50.7% | 1,261 | +41.8% | 0.04% | +50.0% |
| Q2 2019 | $73,000 | +7.4% | 889 | +5.2% | 0.02% | +4.3% |
| Q1 2019 | $68,000 | +33.3% | 845 | +9.6% | 0.02% | +27.8% |
| Q4 2018 | $51,000 | +2.0% | 771 | +18.8% | 0.02% | +5.9% |
| Q3 2018 | $50,000 | +4.2% | 649 | +0.5% | 0.02% | -5.6% |
| Q2 2018 | $48,000 | +17.1% | 646 | +2.1% | 0.02% | +12.5% |
| Q1 2018 | $41,000 | 0.0% | 633 | +1.0% | 0.02% | +6.7% |
| Q4 2017 | $41,000 | +7.9% | 627 | +4.2% | 0.02% | 0.0% |
| Q3 2017 | $38,000 | +5.6% | 602 | 0.0% | 0.02% | 0.0% |
| Q2 2017 | $36,000 | +28.6% | 602 | +9.7% | 0.02% | +25.0% |
| Q1 2017 | $28,000 | -20.0% | 549 | -29.5% | 0.01% | -20.0% |
| Q4 2016 | $35,000 | -2.8% | 779 | +5.3% | 0.02% | -11.8% |
| Q3 2016 | $36,000 | +9.1% | 740 | +1.8% | 0.02% | +6.2% |
| Q2 2016 | $33,000 | +10.0% | 727 | -1.8% | 0.02% | +6.7% |
| Q1 2016 | $30,000 | +15.4% | 740 | +11.1% | 0.02% | +15.4% |
| Q4 2015 | $26,000 | +13.0% | 666 | -8.1% | 0.01% | 0.0% |
| Q3 2015 | $23,000 | – | 725 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |